VANCOUVER, May 1 /CNW/ - Ondine Biopharma Corporation ("the Company",
TSX: OBP; AIM: OBP) today announced the appointment of Mr. Michael Richard
Crane to its Board of Directors. Mr. Crane is an accomplished Senior Executive
who is experienced in the Dental/Medical high-tech equipment and consumables
industry.
